| Abbreviation | Full Name |
| ALK | Anaplastic lymphoma kinase |
| AR | androgen receptors |
| ATTEC | autophagosome-tethering compound |
| AUTAC | autophagy-targeting chimera |
| AZO-PROTACs | azobenzene-proteolysis targeting chimeras |
| BRD4 | Bromodomain-containing protein 4 |
| CDK6 | Cyclin-dependent kinase 6 |
| CDK9 | Cyclin-dependent kinase 9 |
| CI-M6PR | Cation-independent mannose-6-phosphate receptor |
| CLL | Chronic lymphatic leukemia |
| CMA | Chaperone-mediated autophagy |
| CMPD | cell membrane penetrating domain |
| COVID | coronavirus disease |
| CRBN | Cereblon |
| CTM | CMA-targeting motif |
| DAPK1 | death-associated protein kinase 1 |
| DCAF16 | DDB1 and CUL4 associated factor 16 |
| DLBCL | Diffuse large B-cell lymphoma |
| E2F | Early 2 factor |
| EGFR | Epidermal Growth Factor Receptor |
| ER | estrogen receptors |
| ERRα | estrogen-related receptor alpha |
| FBDD | fragment-based drug design |
| FEM1B | fem-1 homolog B |
| FKBP12 | FK506 binding protein 12 |
| FL | Follicular lymphoma |
| FOXO3a | Forkhead box class O3a |
| FRS2α | factor receptor substrate 2α |
| HCV | hepatitis C virus |
| HDAC | Histone deacetylase |
| HH8 | human herpesvirus 8 |
| HPV | human papillomavirus |
| HSC70 | heat shock cognate protein of 70KDa |
| HTLV | human T-lymphocyte virus |
| IAP | Inhibitor of Apoptosis |
| ImiDs | immunomodulatory drugs |
| KRAS | Kirsten rat sarcoma |
| LAMP2A | lysosomal-associated membrane protein 2A |
| LC3 | proteolysis-targeting chimeras |
| LD-ATTEC | lipid droplets ATTEC |
| LTRs | lysosome-targeting receptors |
| M6P | mannose-6-phosphate |
| MCL | Mantle cell lymphoma |
| MDM2 | Mouse double minute 2 |
| MetAp-2 | Methionine Aminopeptidase-2 |
| MetAP2 | methionine aminopeptidase 2 |
| mHTT | Mutant huntingtin protein |
| MZL | Marginal zone lymphoma |
| NF-κB | nuclear factor-κB |
| PCNSL | Primary central nervous system lymphoma |
| pc-PROTAC | photo-caged targeting chimera |
| PDCD4 | programmed cell death 4 |
| PD-L1 | Programmed Cell Death-Ligand 1 |
| PDT | protein degradation technology |
| PEG | poly (ethylene glycol) |
| PhosphoTAC | phospho-dependent proteolysis targeting chimeras |
| PhosTACs | phosphorylation targeting chimeras |
| PHOTAC | photochemically targeting chimera |
| photoPROTACs | Photo-switchable proteolysis targeting chimeras |
| PI3K | phosphatidylinositol-3 kinase |
| POI | protein of interest |
| PROTAC | proteolysis-targeting chimera |
| RBPs | RNA binding proteins |
| RIBOTACs | ribonuclease targeting chimera |
| RIPK2 | Receptor-Interacting Serine/Threonine Protein Kinase 2 |
| RKT | receptor tyrosine kinase |
| RNase | ribonuclease |
| RNF114 | ring finger protein 114 |
| RTK | receptor tyrosine kinase |
| SBDD | structure-based drug design |
| SCF | Skp1-cullin-1-F-box protein |
| Sirt2 | Sirtuin 2 |
| SLL | small lymphatic lymphoma |
| TFs | Transcription factors |
| TrkA | tropomyosin receptor kinase A |
| TSPO | Translocator protein |
| UPS | ubiquitin-proteasome system |
| UVA | ultraviolet A |
| VHL | von Hippel-Lindau |
| WM | Waldenstrom macroglobulinemia |
| βTRCP | β-transducin repeat-containing protein |
| ALK | Anaplastic lymphoma kinase |